Review Articles

Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy

Molecular Oncology and Pharmacology, LBPA CNRS UMR8113, Ecole Normale Supérieure de Cachan, France
Molecular Oncology and Pharmacology, LBPA CNRS UMR8113, Ecole Normale Supérieure de Cachan, France
Molecular Oncology and Pharmacology, LBPA CNRS UMR8113, Ecole Normale Supérieure de Cachan, France;Bioinformatics, Modelisation and Molecular Dynamics, LBPA CNRS UMR8113, Ecole Normale Supérieure de Cachan, France
Molecular Oncology and Pharmacology, LBPA CNRS UMR8113, Ecole Normale Supérieure de Cachan, France
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria;Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria;Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria;Internal Medicine, Small Animal Clinic, Department for Companion Animals and Horses, University of Veterinary Medicine Vienna, Austria
Bioinformatics, Modelisation and Molecular Dynamics, LBPA CNRS UMR8113, Ecole Normale Supérieure de Cachan, France
Ludwig Boltzmann Institute of Cancer Research, Vienna, Austria
Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria;Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria
Molecular Oncology and Pharmacology, LBPA CNRS UMR8113, Ecole Normale Supérieure de Cachan, France;Laboratory of Hematology, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
Vol. 99 No. 3 (2014): March, 2014 https://doi.org/10.3324/haematol.2013.098442